ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Corporate Action, IR, Issuance, Listing Regulation, News, Regulatory, Shares, Swedish
November 18, 2024
29 Dec 2021

Acarix genomför riktad nyemission av aktier till garanter i samband med avslutad företrädesemission

Press release Malmö, 29 december, 2021 Acarix genomför riktad nyemission av aktier till garanter i samband med avslutad f&o...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, Listing Regulation, News, Regulatory, Shares
November 18, 2024
29 Dec 2021

Acarix carries out a directed issue of shares to guarantors in conjunction with completed rights issue

Press release Malmö, December 29, 2021 Acarix carries out a directed issue of shares to guarantors in conjunction with completed ...
Continue reading
author-avatar acarix
Press
August 6, 2024
29 Dec 2021

Acarix genomför riktad nyemission av aktier till garanter i samband med avslutad företrädesemission

Press release Malmö, 29 december, 2021 Acarix genomför riktad nyemission av aktier till garanter i samband med avslutad företrädesemi...
Continue reading
author-avatar acarix
Press
August 6, 2024
29 Dec 2021

Acarix carries out a directed issue of shares to guarantors in conjunction with completed rights issue

Press release Malmö, December 29, 2021 Acarix carries out a directed issue of shares to guarantors in conjunction with completed right...
Continue reading
author-avatar acarix
Press
August 6, 2024
20 Dec 2021

Acarix announce final outcome in rights issue

Press release Malmö, December 20, 2021 Acarix announce final outcome in rights issue Acarix AB ("Acarix" or the "Compa...
Continue reading
author-avatar acarix
Press
August 6, 2024
20 Dec 2021

Acarix offentliggör slutgiltigt utfall i företrädesemission

Press release Malmö, 20 december, 2021 Acarix offentliggör slutgiltigt utfall i företrädesemission Acarix AB ("Acarix" ell...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, Listing Regulation, News, Regulatory, Shares
November 18, 2024
20 Dec 2021

Acarix announce final outcome in rights issue

Press release Malmö, December 20, 2021 Acarix announce final outcome in rights issue Acarix AB ("Acarix" or the "Company") has c...
Continue reading
author-avatar acarix
Corporate Action, IR, Issuance, Listing Regulation, News, Regulatory, Shares, Swedish
November 18, 2024
20 Dec 2021

Acarix offentliggör slutgiltigt utfall i företrädesemission

Press release Malmö, 20 december, 2021 Acarix offentliggör slutgiltigt utfall i företrädesemission Acarix AB ("A...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Listing Regulation, News, Prospectus, Regulatory
November 18, 2024
30 Nov 2021

Acarix publishes prospectus in connection with rights issue of approximately SEK 79 million

Acarix publishes prospectus in connection with rights issue of approximately SEK 79 million The Extraordinary General Meeting of Acari...
Continue reading
author-avatar acarix
Corporate Action, IR, Listing Regulation, News, Prospectus, Regulatory, Swedish
November 18, 2024
30 Nov 2021

Acarix offentliggör prospekt i samband med företrädesemission om cirka 79 MSEK

Acarix offentliggör prospekt i samband med företrädesemission om cirka 79 MSEK Extra bolagsstämman i Acarix AB ("A...
Continue reading
author-avatar acarix
Press
August 6, 2024
30 Nov 2021

Acarix publishes prospectus in connection with rights issue of approximately SEK 79 million

Acarix publishes prospectus in connection with rights issue of approximately SEK 79 million The Extraordinary General Meeting of Acari...
Continue reading
author-avatar acarix
Press
August 6, 2024
30 Nov 2021

Acarix offentliggör prospekt i samband med företrädesemission om cirka 79 MSEK

Acarix offentliggör prospekt i samband med företrädesemission om cirka 79 MSEK Extra bolagsstämman i Acarix AB ("Acarix" ell...
Continue reading
  • «
  • ‹
  • 43
  • 44
  • 45
  • 46
  • 47
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.